Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,633.19 -23.89 -0.28%
TOPIX 723.62 -3.41 -0.47%
Hang Seng 18,717.40 -338.09 -1.77%
Gold 1,551.90 +0.06%
EUR-USD 1.2477 -0.2043%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.33 -0.47%
U.S. 10-year 1.716% -0.029
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: Continuous
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

PRM:SM

3.0500 EUR 0.0100 0.33%

As of 11:38:00 ET on 05/29/2012.

Snapshot for Prim SA (PRM)

Open: 3.0500 Day's Range: 3.0500 - 3.0500 Volume: 2,360 Bid: 3.0500
Previous Close: 3.0600 52wk Range: 3.0100 - 5.4000 1-Yr Rtn: -40.46% Ask: 3.1000

Stock Chart for PRM

No chart data available.
  • PRM:SM 3.0500
  • 1D
  • 1M
  • 1Y
3.0600
Interactive PRM Chart

Previous Close

Key Statistics for PRM

Current P/E Ratio (ttm) 5.8184
Estimated P/E (-) -
Earnings Per Share () (ttm) 0.5242
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 52.91
Shares Outstanding (M) 17.35
Enterprise Value (M EUR) (ttm) 82.49
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) 0.7151
Price/Sale (ttm) 0.5725
Dividend Indicated Gross Yield 6.2371
Next Earnings Announcement 08/31/2012
More PRM Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for PRM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)
More PRM Income Statement Data
  • Total Assets
  • Total Liabilities (M/EUR)
  • Debt to Assets (%)
More PRM Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/EUR)
More PRM Cash Flow Data

Company Profile & Key Executives for PRM

Prim SA operates, develops and manufactures biological/mechanical cardiac prostheses, arterial grafts, mini-video cameras, total hip/knee arthroplasty, medical instruments, diagnostic devices and implantable prosthesis. The Company also markets the German "Hermann F. Borner" natural food supplements and offers treatment of scoliosis.

Victoriano Prim GonzalezChairman/General DirectorCompany RepresentativeVice Chairman
Esperanza Deza AntaChief Financial OfficerCarlos Jose Rodriguez AlvarezSecretary
More Company Profile & Key Executives for PRM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements